The approval is for the 1.2ml and 2.4ml prefilled pen injections that reference AstraZeneca’s Byetta. "Amneal files again for FDA approval of first dihydroergotamine autoinjector" was originally ...
The new authorisation has been granted for a single-dose, pre-filled pen device that requires no ... and AZ'[s twice-daily exenatide formulation, Byetta. After 28 weeks of treatment, patients ...
Hosted on MSN3mon
Amneal gets FDA approval for generic Byetta, resubmits DHE NDAAmneal Pharmaceuticals (NASDAQ:AMRX) has received FDA approval for its generic version of the GLP-1 agonist diabetes drug Byetta and resubmitted its New Drug Application for a prefilled syringe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results